Milligan Sandra
CIK 0001859810
PresidentDirector
Filings
21
Latest May 29, 2026
Issuers covered
4
Showing
21 of 21
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +43.1% | +43.1% | +60.4% | +25.8% |
| 90 days | 2 | 100% | +36.2% | +36.2% | +55.7% | +16.8% |
| 180 days | 2 | 50% | +0.4% | +0.4% | +12.0% | -11.2% |
| 365 days | 1 | 0% | -5.1% | -5.1% | -5.1% | -5.1% |
Issuers
Companies where Milligan Sandra has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| OGN | Organon & Co. | 8 | May 8, 2023 |
| AWH | Aspira Women'S Health Inc. | 5 | Jan 29, 2025 |
| GOSS | Gossamer Bio, Inc. | 5 | Aug 20, 2025 |
| SYRE | Spyre Therapeutics, Inc. | 3 | May 29, 2026 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|